NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA Approval ANDA070252 (HOSPIRA)
NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE) — FDA Approval ANDA070252 (HOSPIRA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: NALOXONE HYDROCHLORIDE; Active ingredients: NALOXONE HYDROCHLORIDE; Application number: ANDA070252.
| Brand name | NALOXONE HYDROCHLORIDE |
|---|---|
| Active ingredients | NALOXONE HYDROCHLORIDE |
| Application number | ANDA070252 |
| Sponsor | HOSPIRA |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19870116 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →